Drug Resistance Updates
Volume 13, Issue 3 , Pages 67-78, June 2010

Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: Implications for future therapeutic approaches

  • Stephen Y. Lai

      Affiliations

    • Department of Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center at Houston, Houston, TX 77030, USA
    • Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center at Houston, Houston, TX 77030, USA
    • ,
  • Faye M. Johnson

      Affiliations

    • Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center at Houston, Houston, TX 77030, USA
    • The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX 77030, USA
    • Corresponding Author InformationCorresponding author at: The University of Texas M.D. Anderson, Cancer Center, 1515 Holcombe Blvd., Department of Thoracic/Head and Neck Medical Oncology, Box 432, Houston, TX 77030, USA. Tel.: +1 713 792 6363; fax: +1 713 792 1220.

Received 24 March 2010; accepted 6 April 2010. published online 17 May 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1368-7646(10)00018-X

doi:10.1016/j.drup.2010.04.001

Drug Resistance Updates
Volume 13, Issue 3 , Pages 67-78, June 2010

Article Tools

* Image Usage & Resolution